India faces a significant burden of the sickle cell disease — where red blood cells become sickle-shaped, reducing ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

A couple from Sible Hedingham have set up a charity in memory of their 7-year-old son, who passed away in a medical trial last year.

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

Blood banks regularly update information on this platform, making it easier for patients suffering from thalassemia, ...

Union Minister Nitin Gadkari commended the Smrutishesh Madhukarrao Tamgadge Charitable Trust, led by IPS officer Sandeep ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...